Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 5 June, 2025
Notification of sale of treasury shares as of 4 June,2025
Sofia, Bulgaria, June 4, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 3, 2025 the Company sold 12 000 (twelve thousand) repurchased own shares representing 0.007% of the share capital of the Company, at a total value of BGN 80 440 on the Bulgarian Stock Exchange, the average price per share was BGN 6,70.
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 4 June, 2025
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 4 June, 2025
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 4 June, 2025
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 3 June, 2025
Notification of sale of treasury shares as of 3 June, 2025
Sofia, Bulgaria, June 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 2, 2025 the Company sold 5 000 (five thousand) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 33 560 on the Bulgarian Stock Exchange, the average price per share was BGN 6,71.
Declaration by the responsible directors as at 31 March 2025
Information according to Annex 4 of Ordinance 2 as at 31 March 2025
Strony
- « pierwsza
- ‹ poprzednia
- …
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- następna ›
- ostatnia »